| Inflammation and atherosclerosis P Libby, PM Ridker, A Maseri Circulation 105 (9), 1135-1143, 2002 | 23802 | 2002 |
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein PM Ridker, E Danielson, FAH Fonseca, J Genest, AM Gotto Jr, ... New England journal of medicine 359 (21), 2195-2207, 2008 | 8916 | 2008 |
| Antiinflammatory therapy with canakinumab for atherosclerotic disease PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ... New England journal of medicine 377 (12), 1119-1131, 2017 | 8488 | 2017 |
| From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I M Naghavi, P Libby, E Falk, SW Casscells, S Litovsky, J Rumberger, ... Circulation 108 (14), 1664-1672, 2003 | 5007 | 2003 |
| Progress and challenges in translating the biology of atherosclerosis P Libby, PM Ridker, GK Hansson Nature 473 (7347), 317-325, 2011 | 4909 | 2011 |
| Diabetes and atherosclerosis: epidemiology, pathophysiology, and management JA Beckman, MA Creager, P Libby Jama 287 (19), 2570-2581, 2002 | 4258 | 2002 |
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. ZS Galis, GK Sukhova, MW Lark, P Libby The Journal of clinical investigation 94 (6), 2493-2503, 1994 | 3449 | 1994 |
| Molecular bases of the acute coronary syndromes P Libby Circulation 91 (11), 2844-2850, 1995 | 3304 | 1995 |
| Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial SE Nissen, SJ Nicholls, I Sipahi, P Libby, JS Raichlen, CM Ballantyne, ... Jama 295 (13), 1556-1565, 2006 | 3245 | 2006 |
| The immune response in atherosclerosis: a double-edged sword GK Hansson, P Libby Nature reviews immunology 6 (7), 508-519, 2006 | 2983 | 2006 |
| Inflammation in atherosclerosis P Libby Arteriosclerosis, thrombosis, and vascular biology 32 (9), 2045-2051, 2012 | 2893 | 2012 |
| Current concepts of the pathogenesis of the acute coronary syndromes P Libby Circulation 104 (3), 365-372, 2001 | 2838 | 2001 |
| Pathophysiology of coronary artery disease P Libby, P Theroux Circulation 111 (25), 3481-3488, 2005 | 2837 | 2005 |
| The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions M Nahrendorf, FK Swirski, E Aikawa, L Stangenberg, T Wurdinger, ... The Journal of experimental medicine 204 (12), 3037-3047, 2007 | 2659 | 2007 |
| Inflammation in atherosclerosis: from pathophysiology to practice P Libby, PM Ridker, GK Hansson, ... Journal of the American college of cardiology 54 (23), 2129-2138, 2009 | 2652 | 2009 |
| Identification of splenic reservoir monocytes and their deployment to inflammatory sites FK Swirski, M Nahrendorf, M Etzrodt, M Wildgruber, V Cortez-Retamozo, ... Science 325 (5940), 612-616, 2009 | 2649 | 2009 |
| Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. R De Caterina, P Libby, HB Peng, VJ Thannickal, TB Rajavashisth, ... The Journal of clinical investigation 96 (1), 60-68, 1995 | 2344 | 1995 |
| Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease S Jaiswal, P Natarajan, AJ Silver, CJ Gibson, AG Bick, E Shvartz, ... New England Journal of Medicine 377 (2), 111-121, 2017 | 2273 | 2017 |
| Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor–deficient mice L Gu, Y Okada, SK Clinton, C Gerard, GK Sukhova, P Libby, BJ Rollins Molecular cell 2 (2), 275-281, 1998 | 2269 | 1998 |
| Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial SE Nissen, EM Tuzcu, P Libby, PD Thompson, M Ghali, D Garza, ... Jama 292 (18), 2217-2225, 2004 | 1936 | 2004 |